Biosimilars and Follow-On Biologics Market Opportunities 2025-2033

добавлена новая статья Health

2025-08-21 09:15:33 -

According to FutureWise analysis, the market for biosimilars and follow-on biologics in 2023 is US$26.03 billion, and is expected to reach US$83.69 billion by 2031 at a CAGR of 15.70%. Biosimilars are biological products designed to be highly similar to an already approved (licensed) drug, known as the reference product, as determined by regulatory authorities such as the Food and Drug...

0 Комментарии 0 Поделились 114 Просмотры 0 предпросмотр